Table 1.
General characteristics of the patients
| Characteristic | No (%) |
|---|---|
| Total | 107 |
| Age (y) | 4.268 ± 3.294 |
| Gender, No. (%) | |
| Male | 55(51.40) |
| Female | 52(48.60) |
| Underlying diseases, No. (%) | |
| None | 98(91.59) |
| Congenital heart disease | 5(4.67) |
| Congenital biliary atresia | 2(1.87) |
| Other diseases | 2(1.87) |
| Symptoms and signs | |
| Fever, No. (%) | 100(93.46) |
| Duration of fever (d) | 7.690 ± 5.770 |
| Cough, No. (%) | 107(100) |
| Wheezing, No. (%) | 20(18.69) |
| Duration of wheezing (d) | 0.00(0.00,5.00) |
| RMPP, No. (%) | 56(52.34) |
| Hypoxemia, No. (%) | 16(14.95) |
| Mechanical ventilation, No. (%) | 7(6.54) |
| Application of glucocorticoids, No. (%) | 60(56.07) |
| Replacement of antibiotics, No. (%) | 19(17.76) |
| 7-day course of azithromycin, No. (%) | 42(39.25) |
| Coinfection, No. (%) | 60(56.07) |
| MP with A2063G mutation, No. (%) | 60(56.07) |
| Prognosis after treatment, No. (%) | |
| Surviving | 105(98.13) |
| Nonsurviving | 2(1.87) |
Data are No. (%) of patients, mean ± standard deviation (SD) or median (interquartile range)